Related Experiment Video
Updated: May 1, 2026

Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
Comparative virology and pathology of Monkeypox virus in Syrian hamsters, C57BL/6, and BALB/c mice: A framework for
Xiaohui Wei1, Jing Wu1, Hekai Yang1
1NHC Key Laboratory of Human Disease Comparative Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Center of Technology Innovation for Animal Model, Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
Abstract:
Monkeypox virus (MPXV), a zoonotic orthopoxvirus, has emerged as a major public health concern following its global spread in 2022. Robust small animal models are urgently needed to investigate MPXV pathogenesis and evaluate medical countermeasures. Here, we systematically compared MPXV infection in Syrian hamsters, C57BL/6 mice, and BALB/c mice following intraperitoneal inoculation. Syrian hamsters displayed the highest susceptibility, with systemic viral dissemination peaking at 2 days post-infection (dpi) and clearance by 12 dpi. Viral burdens were particularly elevated in the spleen and kidneys, correlating with severe histopathological changes. In contrast, C57BL/6 and BALB/c mice exhibited more restricted viral replication, with the kidneys, liver, and spleen serving as major target organs. Across all models, no cutaneous lesions were observed, underscoring the influence of infection route on disease phenotype. Comparative analysis revealed species-specific tissue tropism and clearance kinetics, confirming the Syrian hamster as a permissive model for systemic MPXV disease, while C57BL/6 and BALB/c mice offer complementary value for mechanistic immunology studies. These findings establish a framework for rational selection of small animal models to study MPXV pathogenesis and to evaluate antiviral and vaccine strategies.

